Zobrazeno 1 - 10
of 45
pro vyhledávání: '"Kyung Mann Kim"'
Autor:
Orly Vardeny, Jacob A. Udell, Ankeet S. Bhatt, Jacob Joseph, Scott D. Solomon, Kyung Mann Kim
Publikováno v:
European Heart Journal
The link between viral respiratory infection and non-pulmonary organ-specific injury, including cardiac injury, has become increasingly appreciated during the current coronavirus disease 2019 (COVID-19) pandemic. Even prior to the pandemic, however,
Autor:
Zachary S. Morris, Paul A. Clark, Ian S. Arthur, Won Jong Jin, Kelsey A Klar, Jonathan A. Lubin, Jasdeep S. Kler, Amber M. Bates, John S. Kuo, Ishan Chakravarty, Bryce R. Anderson, Raghava N. Sriramaneni, Emily I. Guy, Justin C. Jagodinsky, Abigail A Jaquish, Trang T. Le, Clinton M. Heinze, Peter M. Carlson, Kyung Mann Kim
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundImmune checkpoint inhibition (ICI) alone is not efficacious for a large number of patients with melanoma brain metastases. We previously established an in situ vaccination (ISV) regimen combining radiation and immunocytokine to enhance resp
Autor:
Elisabeth Paietta, Fangxin Hong, Brad S. Kahl, Kyung Mann Kim, Vaishalee P. Kenkre, Bartosz Grzywacz, Erik A. Ranheim, Patrick K. Reville, Lakeesha Carmichael, Eneida A. Mendonça, Amy K. Erbe, Wei Wang, Paul M. Sondel, Sandra J. Horning, Anna Hoefges, Yiqiang Song, Songwon Seo, Jeffrey S. Miller, Randy D. Gascoyne, Jacquelyn A. Hank
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)
Background The ECOG-ACRIN Cancer Research Group evaluated rituximab treatment schedules for patients with newly-diagnosed low-tumor-burden follicular-lymphoma (FL). All patients received 4-weekly rituximab treatments as induction therapy. Clinically-
Autor:
Natalie S. Callander, Peiman Hematti, Kaitlin M. Woo, Vaishalee P. Kenkre, Mark B. Juckett, Walter L. Longo, Kyung Mann Kim, Aric C. Hall, Ryan J. Mattison, Christopher D'Angelo
Publikováno v:
Leuk Res
Patients with high-risk myelodysplastic syndrome or acute myeloid leukemia have an increased risk of death following allogeneic hematopoietic stem cell transplantation (allo-HSCT). Decitabine has minimal non-hematologic toxicity and proven efficacy i
Publikováno v:
Biometrics. 72:986-994
Zero-inflated regression models have emerged as a popular tool within the parametric framework to characterize count data with excess zeros. Despite their increasing popularity, much of the literature on real applications of these models has centered
Autor:
Shaun G. Goodman, Jon Temte, J. Michael Gaziano, Christopher P. Cannon, A. McGeer, Inder S. Anand, Jacob Joseph, Kyung Mann Kim, David L. DeMets, Orly Vardeny, Adrian F. Hernandez, Clyde W. Yancy, H. Keipp Talbot, Lawton S. Cooper, Michael E. Farkouh, Kristin L. Nichol, Scott D. Solomon, Deepak L. Bhatt, Jacob A. Udell, Janet Wittes
Publikováno v:
American heart journal. 202
BACKGROUND: Influenza leads to significant cardiopulmonary morbidity and mortality, particularly in patients with cardiovascular disease, that may be prevented with a standard influenza vaccine. However, patients with cardiovascular conditions have a
Autor:
Mark R. Albertini, Tae Won Kim, Yaohui G. Xu, Thomas C. Havighurst, Vladimir S. Spiegelman, Kyung Mann Kim
Melanoma is one of the deadliest forms of skin cancer. Although BRAF inhibitors significantly enhance survival of metastatic melanoma patients, most patients relapse after less than a year of treatment. We previously reported that mRNA binding protei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0ef3e3e55644c08e0162cc67c0cf7d9
https://europepmc.org/articles/PMC6408214/
https://europepmc.org/articles/PMC6408214/
Autor:
Arielle Baim, Jules H. Blank, Sandeep Saha, Harish Ahuja, Anne M. Traynor, Timothy S. Fenske, Ryan J. Mattison, Tim Wassenaar, Kyung Mann Kim, Namrata Shah, Patrick Mansky, Rubina Qamar, Chong Zhang, John P. Farnen, Brad S. Kahl, Adedayo A. Onitilo
Publikováno v:
Cancer. 121:3465-3471
BACKGROUND Proteasome inhibitors and mammalian target of rapamycin inhibitors each have activity in various B-cell malignancies and affect distinct cellular pathways. Their combination has demonstrated synergy in vitro and in mouse models. METHODS Th
Autor:
Scott J. Hebbring, Kyung Mann Kim, Tae Won Kim, Juliet L. Aylward, Vladimir S. Spiegelman, Yaohui G. Xu, Zhan Ye, Thomas C. Havighurst, Sunduz Keles
Publikováno v:
The Journal of investigative dermatology. 137(3)
Autor:
Yiqiang Song, Su-Chun Chen, David F. McDermott, David J. Panka, MIkayla Gallendberger, Amy K. Erbe, Jacquelyn A. Hank, Laskeesha Carmichael, Kyung Mann Kim, Wei Wang, Dustin Hess, Alexander Carlson, Sabina Signoretti, Eneida A. Mendonça, Paul M. Sondel, James W. Mier, Michael B. Atkins
Publikováno v:
Journal for Immunotherapy of Cancer
HD-IL2 was given to patients with mRCC in a prospective trial (ClinicalTrials.gov ID: NCT00554515) that demonstrated an overall response rate of 25%. To identify predictors of response, we genotyped patients for single nucleotide polymorphisms (SNPs)